nodes	percent_of_prediction	percent_of_DWPC	metapath
Halothane—RHO—epithelium—cervical cancer	0.0411	0.0486	CbGeAlD
Halothane—KCNN4—exocrine gland—cervical cancer	0.0309	0.0365	CbGeAlD
Halothane—ND1—exocrine gland—cervical cancer	0.029	0.0343	CbGeAlD
Halothane—KCNJ6—female reproductive system—cervical cancer	0.0285	0.0338	CbGeAlD
Halothane—GNG2—decidua—cervical cancer	0.025	0.0296	CbGeAlD
Halothane—KCNMA1—exocrine gland—cervical cancer	0.0236	0.0279	CbGeAlD
Halothane—GNG2—female reproductive system—cervical cancer	0.0197	0.0233	CbGeAlD
Halothane—KCNK10—renal system—cervical cancer	0.0187	0.0221	CbGeAlD
Halothane—GNG2—female gonad—cervical cancer	0.0179	0.0212	CbGeAlD
Halothane—GNG2—vagina—cervical cancer	0.0178	0.021	CbGeAlD
Halothane—KCNK3—renal system—cervical cancer	0.0169	0.02	CbGeAlD
Halothane—GLRB—uterine cervix—cervical cancer	0.0157	0.0185	CbGeAlD
Halothane—KCNK3—female reproductive system—cervical cancer	0.0135	0.016	CbGeAlD
Halothane—KCNN4—epithelium—cervical cancer	0.0134	0.0159	CbGeAlD
Halothane—KCNN4—decidua—cervical cancer	0.0127	0.015	CbGeAlD
Halothane—KCNK2—vagina—cervical cancer	0.0127	0.015	CbGeAlD
Halothane—KCNN4—endometrium—cervical cancer	0.012	0.0142	CbGeAlD
Halothane—ND1—renal system—cervical cancer	0.0117	0.0139	CbGeAlD
Halothane—GNG2—lymph node—cervical cancer	0.0115	0.0136	CbGeAlD
Halothane—KCNN4—uterus—cervical cancer	0.0111	0.0131	CbGeAlD
Halothane—GLRB—vagina—cervical cancer	0.0106	0.0126	CbGeAlD
Halothane—KCNMA1—epithelium—cervical cancer	0.0103	0.0122	CbGeAlD
Halothane—ATP5D—uterine cervix—cervical cancer	0.0101	0.0119	CbGeAlD
Halothane—KCNN4—female reproductive system—cervical cancer	0.00997	0.0118	CbGeAlD
Halothane—ATP2C1—uterine cervix—cervical cancer	0.00996	0.0118	CbGeAlD
Halothane—GABRP—uterine cervix—cervical cancer	0.00976	0.0116	CbGeAlD
Halothane—KCNMA1—decidua—cervical cancer	0.0097	0.0115	CbGeAlD
Halothane—ATP5D—decidua—cervical cancer	0.00961	0.0114	CbGeAlD
Halothane—KCNMA1—renal system—cervical cancer	0.00952	0.0113	CbGeAlD
Halothane—ATP2C1—decidua—cervical cancer	0.00949	0.0112	CbGeAlD
Halothane—ATP5D—renal system—cervical cancer	0.00944	0.0112	CbGeAlD
Halothane—ND1—female reproductive system—cervical cancer	0.00938	0.0111	CbGeAlD
Halothane—ATP2C1—renal system—cervical cancer	0.00931	0.011	CbGeAlD
Halothane—GABRP—decidua—cervical cancer	0.0093	0.011	CbGeAlD
Halothane—ATP5D—endometrium—cervical cancer	0.00912	0.0108	CbGeAlD
Halothane—KCNN4—vagina—cervical cancer	0.00902	0.0107	CbGeAlD
Halothane—ATP2C1—endometrium—cervical cancer	0.00901	0.0107	CbGeAlD
Halothane—GRIN2A—vagina—cervical cancer	0.00885	0.0105	CbGeAlD
Halothane—GABRP—endometrium—cervical cancer	0.00883	0.0104	CbGeAlD
Halothane—ATP5D—mammalian vulva—cervical cancer	0.00883	0.0104	CbGeAlD
Halothane—ATP2C1—mammalian vulva—cervical cancer	0.00871	0.0103	CbGeAlD
Halothane—GABRA4—mammalian vulva—cervical cancer	0.0086	0.0102	CbGeAlD
Halothane—ND1—female gonad—cervical cancer	0.00853	0.0101	CbGeAlD
Halothane—KCNMA1—uterus—cervical cancer	0.00848	0.01	CbGeAlD
Halothane—ATP5D—uterus—cervical cancer	0.00841	0.00995	CbGeAlD
Halothane—ATP2C1—uterus—cervical cancer	0.0083	0.00982	CbGeAlD
Halothane—KCNK2—lymph node—cervical cancer	0.00819	0.0097	CbGeAlD
Halothane—GABRP—uterus—cervical cancer	0.00813	0.00963	CbGeAlD
Halothane—NPSR1—G alpha (s) signalling events—TAAR6—cervical cancer	0.00777	0.0501	CbGpPWpGaD
Halothane—KCNMA1—female reproductive system—cervical cancer	0.00763	0.00903	CbGeAlD
Halothane—ATP5D—female reproductive system—cervical cancer	0.00756	0.00894	CbGeAlD
Halothane—ATP2C1—female reproductive system—cervical cancer	0.00746	0.00883	CbGeAlD
Halothane—GABRE—uterine cervix—cervical cancer	0.00745	0.00882	CbGeAlD
Halothane—GABRB1—vagina—cervical cancer	0.00738	0.00874	CbGeAlD
Halothane—GABRP—female reproductive system—cervical cancer	0.00731	0.00865	CbGeAlD
Halothane—GABRE—decidua—cervical cancer	0.0071	0.0084	CbGeAlD
Halothane—ATP5D—female gonad—cervical cancer	0.00688	0.00814	CbGeAlD
Halothane—GLRB—lymph node—cervical cancer	0.00686	0.00812	CbGeAlD
Halothane—ATP5D—vagina—cervical cancer	0.00684	0.00809	CbGeAlD
Halothane—ATP2C1—female gonad—cervical cancer	0.00679	0.00803	CbGeAlD
Halothane—ATP2C1—vagina—cervical cancer	0.00675	0.00798	CbGeAlD
Halothane—GABRE—endometrium—cervical cancer	0.00674	0.00797	CbGeAlD
Halothane—GABRP—vagina—cervical cancer	0.00661	0.00783	CbGeAlD
Halothane—GABRE—mammalian vulva—cervical cancer	0.00652	0.00771	CbGeAlD
Halothane—KCNJ3—G Protein Signaling Pathways—AKAP13—cervical cancer	0.00643	0.0415	CbGpPWpGaD
Halothane—KCNN4—lymph node—cervical cancer	0.00583	0.0069	CbGeAlD
Halothane—CYP2A6—vagina—cervical cancer	0.00576	0.00682	CbGeAlD
Halothane—GNG2—PAR1-mediated thrombin signaling events—AKAP13—cervical cancer	0.00563	0.0364	CbGpPWpGaD
Halothane—GABRE—female reproductive system—cervical cancer	0.00558	0.00661	CbGeAlD
Halothane—ND1—lymph node—cervical cancer	0.00549	0.00649	CbGeAlD
Halothane—GABRA2—vagina—cervical cancer	0.00509	0.00603	CbGeAlD
Halothane—GABRE—female gonad—cervical cancer	0.00508	0.00601	CbGeAlD
Halothane—GABRE—vagina—cervical cancer	0.00505	0.00597	CbGeAlD
Halothane—GABRB3—female reproductive system—cervical cancer	0.00473	0.0056	CbGeAlD
Halothane—KCNMA1—lymph node—cervical cancer	0.00446	0.00528	CbGeAlD
Halothane—ATP5D—lymph node—cervical cancer	0.00442	0.00523	CbGeAlD
Halothane—ATP2C1—lymph node—cervical cancer	0.00436	0.00516	CbGeAlD
Halothane—CYP2B6—renal system—cervical cancer	0.00401	0.00474	CbGeAlD
Halothane—CYP2E1—renal system—cervical cancer	0.00376	0.00445	CbGeAlD
Halothane—NPSR1—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.0037	0.0239	CbGpPWpGaD
Halothane—GNG2—Ca2+ pathway—WNT5A—cervical cancer	0.00368	0.0237	CbGpPWpGaD
Halothane—GNG2—Class B/2 (Secretin family receptors)—WNT2—cervical cancer	0.00365	0.0236	CbGpPWpGaD
Halothane—GNG2—G alpha (12/13) signalling events—AKAP13—cervical cancer	0.00361	0.0233	CbGpPWpGaD
Halothane—GNG2—G alpha (s) signalling events—TAAR6—cervical cancer	0.00352	0.0227	CbGpPWpGaD
Halothane—GNG2—Platelet activation, signaling and aggregation—GP6—cervical cancer	0.00335	0.0216	CbGpPWpGaD
Halothane—GABRA2—lymph node—cervical cancer	0.00329	0.0039	CbGeAlD
Halothane—GABRE—lymph node—cervical cancer	0.00327	0.00386	CbGeAlD
Halothane—CYP2B6—female reproductive system—cervical cancer	0.00321	0.0038	CbGeAlD
Halothane—CYP2C9—female reproductive system—cervical cancer	0.00318	0.00376	CbGeAlD
Halothane—CYP3A4—renal system—cervical cancer	0.00302	0.00358	CbGeAlD
Halothane—CYP2E1—female reproductive system—cervical cancer	0.00301	0.00356	CbGeAlD
Halothane—ALB—lymph node—cervical cancer	0.00298	0.00352	CbGeAlD
Halothane—CYP2D6—renal system—cervical cancer	0.00298	0.00352	CbGeAlD
Halothane—GNG2—Platelet activation, signaling and aggregation—GP5—cervical cancer	0.00293	0.0189	CbGpPWpGaD
Halothane—CYP2B6—vagina—cervical cancer	0.0029	0.00343	CbGeAlD
Halothane—RHO—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00287	0.0185	CbGpPWpGaD
Halothane—NPSR1—GPCR ligand binding—TAAR6—cervical cancer	0.00282	0.0182	CbGpPWpGaD
Halothane—GNG2—Class B/2 (Secretin family receptors)—WNT5A—cervical cancer	0.00277	0.0179	CbGpPWpGaD
Halothane—CYP3A4—female reproductive system—cervical cancer	0.00242	0.00287	CbGeAlD
Halothane—CYP2D6—female reproductive system—cervical cancer	0.00238	0.00282	CbGeAlD
Halothane—CYP2E1—Folate-Alcohol and Cancer Pathway—MTHFR—cervical cancer	0.00231	0.0149	CbGpPWpGaD
Halothane—NPSR1—GPCR ligand binding—WNT2—cervical cancer	0.0022	0.0142	CbGpPWpGaD
Halothane—RHO—GPCR ligand binding—TAAR6—cervical cancer	0.00219	0.0141	CbGpPWpGaD
Halothane—CYP2D6—female gonad—cervical cancer	0.00217	0.00257	CbGeAlD
Halothane—GNG2—beta-catenin independent WNT signaling—WNT5A—cervical cancer	0.00186	0.012	CbGpPWpGaD
Halothane—KCNMA1—Circadian rythm related genes—UBE3A—cervical cancer	0.00185	0.012	CbGpPWpGaD
Halothane—GNG2—CXCR3-mediated signaling events—MTOR—cervical cancer	0.00175	0.0113	CbGpPWpGaD
Halothane—KCNMA1—Hemostasis—SERPIND1—cervical cancer	0.00174	0.0112	CbGpPWpGaD
Halothane—KCNMA1—Hemostasis—GP6—cervical cancer	0.00174	0.0112	CbGpPWpGaD
Halothane—GNG2—Hemostasis—SERPIND1—cervical cancer	0.00173	0.0111	CbGpPWpGaD
Halothane—GNG2—Hemostasis—GP6—cervical cancer	0.00173	0.0111	CbGpPWpGaD
Halothane—RHO—GPCR ligand binding—WNT2—cervical cancer	0.00171	0.011	CbGpPWpGaD
Halothane—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.0017	0.011	CbGpPWpGaD
Halothane—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.00167	0.0108	CbGpPWpGaD
Halothane—NPSR1—GPCR ligand binding—WNT5A—cervical cancer	0.00167	0.0108	CbGpPWpGaD
Halothane—CYP2E1—Tryptophan metabolism—UBE3A—cervical cancer	0.00161	0.0104	CbGpPWpGaD
Halothane—NPSR1—GPCR downstream signaling—TAAR6—cervical cancer	0.00159	0.0103	CbGpPWpGaD
Halothane—KCNMA1—Hemostasis—GP5—cervical cancer	0.00152	0.0098	CbGpPWpGaD
Halothane—GNG2—Hemostasis—GP5—cervical cancer	0.00151	0.00974	CbGpPWpGaD
Halothane—CYP2A6—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.00148	0.00953	CbGpPWpGaD
Halothane—NPSR1—Signaling by GPCR—TAAR6—cervical cancer	0.00145	0.00934	CbGpPWpGaD
Halothane—CYP2E1—Vitamin A and Carotenoid Metabolism—RARB—cervical cancer	0.00138	0.00893	CbGpPWpGaD
Halothane—GNG2—Signaling by Wnt—WNT2—cervical cancer	0.0013	0.00838	CbGpPWpGaD
Halothane—RHO—GPCR ligand binding—WNT5A—cervical cancer	0.00129	0.00835	CbGpPWpGaD
Halothane—GNG2—GPCR ligand binding—TAAR6—cervical cancer	0.00128	0.00825	CbGpPWpGaD
Halothane—RHO—GPCR downstream signaling—TAAR6—cervical cancer	0.00124	0.00798	CbGpPWpGaD
Halothane—RHO—Integrated Breast Cancer Pathway—CASP8—cervical cancer	0.0012	0.00777	CbGpPWpGaD
Halothane—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.00117	0.00758	CbGpPWpGaD
Halothane—NPSR1—Signaling by GPCR—WNT2—cervical cancer	0.00113	0.00729	CbGpPWpGaD
Halothane—GNG2—TSH signaling pathway—MTOR—cervical cancer	0.00112	0.00725	CbGpPWpGaD
Halothane—RHO—Signaling by GPCR—TAAR6—cervical cancer	0.00112	0.00724	CbGpPWpGaD
Halothane—NPSR1—GPCR downstream signaling—AKAP13—cervical cancer	0.00109	0.00705	CbGpPWpGaD
Halothane—GNG2—Ca2+ pathway—CTNNB1—cervical cancer	0.00106	0.00685	CbGpPWpGaD
Halothane—GNG2—LPA receptor mediated events—CASP3—cervical cancer	0.00106	0.00684	CbGpPWpGaD
Halothane—CYP2A6—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.00103	0.00666	CbGpPWpGaD
Halothane—GNG2—GPCR ligand binding—WNT2—cervical cancer	0.000999	0.00644	CbGpPWpGaD
Halothane—NPSR1—Signaling by GPCR—AKAP13—cervical cancer	0.000992	0.0064	CbGpPWpGaD
Halothane—RHO—Integrated Breast Cancer Pathway—MTOR—cervical cancer	0.000991	0.0064	CbGpPWpGaD
Halothane—GNG2—Signaling by Wnt—WNT5A—cervical cancer	0.000984	0.00635	CbGpPWpGaD
Halothane—GRIN2A—Alzheimers Disease—CASP8—cervical cancer	0.000966	0.00623	CbGpPWpGaD
Halothane—GNG2—CXCR4-mediated signaling events—MTOR—cervical cancer	0.000927	0.00598	CbGpPWpGaD
Halothane—GNG2—CXCR4-mediated signaling events—CD4—cervical cancer	0.000925	0.00597	CbGpPWpGaD
Halothane—RHO—Integrated Breast Cancer Pathway—CASP3—cervical cancer	0.000912	0.00588	CbGpPWpGaD
Halothane—GNG2—Thromboxane A2 receptor signaling—EGFR—cervical cancer	0.0009	0.00581	CbGpPWpGaD
Halothane—RHO—Integrated Breast Cancer Pathway—CTNNB1—cervical cancer	0.000879	0.00567	CbGpPWpGaD
Halothane—RHO—Signaling by GPCR—WNT2—cervical cancer	0.000876	0.00565	CbGpPWpGaD
Halothane—GNG2—TSH signaling pathway—STAT3—cervical cancer	0.000869	0.0056	CbGpPWpGaD
Halothane—NPSR1—Signaling by GPCR—WNT5A—cervical cancer	0.000856	0.00553	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—TAAR6—cervical cancer	0.000855	0.00552	CbGpPWpGaD
Halothane—RHO—GPCR downstream signaling—AKAP13—cervical cancer	0.000847	0.00547	CbGpPWpGaD
Halothane—KCNK10—Ectoderm Differentiation—CTNNB1—cervical cancer	0.000809	0.00522	CbGpPWpGaD
Halothane—GNG2—LPA receptor mediated events—EGFR—cervical cancer	0.000809	0.00522	CbGpPWpGaD
Halothane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000775	0.005	CbGpPWpGaD
Halothane—ALB—Platelet activation, signaling and aggregation—GP6—cervical cancer	0.000773	0.00499	CbGpPWpGaD
Halothane—RHO—Signaling by GPCR—AKAP13—cervical cancer	0.000769	0.00496	CbGpPWpGaD
Halothane—GNG2—GPCR ligand binding—WNT5A—cervical cancer	0.000757	0.00488	CbGpPWpGaD
Halothane—CYP3A4—Tryptophan metabolism—UBE3A—cervical cancer	0.000746	0.00481	CbGpPWpGaD
Halothane—RHO—Disease—WNT2—cervical cancer	0.000739	0.00477	CbGpPWpGaD
Halothane—GRIN2A—Alzheimers Disease—CASP3—cervical cancer	0.000731	0.00471	CbGpPWpGaD
Halothane—GNG2—GPCR downstream signaling—TAAR6—cervical cancer	0.000723	0.00466	CbGpPWpGaD
Halothane—GNG2—CXCR4-mediated signaling events—STAT3—cervical cancer	0.000716	0.00462	CbGpPWpGaD
Halothane—RHO—Integrated Breast Cancer Pathway—EGFR—cervical cancer	0.000696	0.00449	CbGpPWpGaD
Halothane—NPSR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000677	0.00437	CbGpPWpGaD
Halothane—ALB—Platelet activation, signaling and aggregation—GP5—cervical cancer	0.000676	0.00436	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—WNT2—cervical cancer	0.000668	0.00431	CbGpPWpGaD
Halothane—RHO—Signaling by GPCR—WNT5A—cervical cancer	0.000664	0.00428	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—TAAR6—cervical cancer	0.000663	0.00428	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—TAAR6—cervical cancer	0.000656	0.00424	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—AKAP13—cervical cancer	0.000586	0.00378	CbGpPWpGaD
Halothane—RHO—Integrated Breast Cancer Pathway—TP53—cervical cancer	0.000585	0.00377	CbGpPWpGaD
Halothane—RHO—Disease—WNT5A—cervical cancer	0.00056	0.00361	CbGpPWpGaD
Halothane—GNG2—beta-catenin independent WNT signaling—CTNNB1—cervical cancer	0.000537	0.00346	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—WNT2—cervical cancer	0.000518	0.00334	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—WNT2—cervical cancer	0.000512	0.00331	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—WNT5A—cervical cancer	0.000506	0.00326	CbGpPWpGaD
Halothane—GNG2—Signaling by Wnt—TERT—cervical cancer	0.000496	0.0032	CbGpPWpGaD
Halothane—GNG2—GPCR downstream signaling—AKAP13—cervical cancer	0.000495	0.0032	CbGpPWpGaD
Halothane—ALB—Vitamin B12 Metabolism—MTHFR—cervical cancer	0.000495	0.00319	CbGpPWpGaD
Halothane—GRIN2A—Alzheimers Disease—TP53—cervical cancer	0.000468	0.00302	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—AKAP13—cervical cancer	0.000454	0.00293	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—AKAP13—cervical cancer	0.00045	0.0029	CbGpPWpGaD
Halothane—ATP5D—Metabolism—CA9—cervical cancer	0.000433	0.00279	CbGpPWpGaD
Halothane—ND1—Metabolism—CA9—cervical cancer	0.000433	0.00279	CbGpPWpGaD
Halothane—ALB—Folate Metabolism—MTHFR—cervical cancer	0.000403	0.0026	CbGpPWpGaD
Halothane—GABRA1—SIDS Susceptibility Pathways—HES1—cervical cancer	0.000402	0.0026	CbGpPWpGaD
Halothane—ALB—Hemostasis—GP6—cervical cancer	0.000398	0.00257	CbGpPWpGaD
Halothane—ALB—Hemostasis—SERPIND1—cervical cancer	0.000398	0.00257	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—WNT5A—cervical cancer	0.000392	0.00253	CbGpPWpGaD
Halothane—CYP2A6—Fluoropyrimidine Activity—TP53—cervical cancer	0.000392	0.00253	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—WNT5A—cervical cancer	0.000388	0.00251	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—TAAR6—cervical cancer	0.000388	0.0025	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—NOTCH2—cervical cancer	0.000355	0.00229	CbGpPWpGaD
Halothane—ALB—Hemostasis—GP5—cervical cancer	0.000348	0.00225	CbGpPWpGaD
Halothane—GNG2—Metabolism—CA9—cervical cancer	0.000342	0.00221	CbGpPWpGaD
Halothane—RHO—Disease—HES1—cervical cancer	0.000322	0.00208	CbGpPWpGaD
Halothane—ALB—Selenium Micronutrient Network—MTHFR—cervical cancer	0.00032	0.00206	CbGpPWpGaD
Halothane—GNG2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000307	0.00198	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—WNT2—cervical cancer	0.000303	0.00195	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—HES1—cervical cancer	0.000291	0.00188	CbGpPWpGaD
Halothane—GNG2—Signaling by Wnt—CTNNB1—cervical cancer	0.000284	0.00183	CbGpPWpGaD
Halothane—RHO—Disease—MTHFR—cervical cancer	0.000283	0.00183	CbGpPWpGaD
Halothane—GABRB3—BDNF signaling pathway—MTOR—cervical cancer	0.000283	0.00182	CbGpPWpGaD
Halothane—RHO—Disease—TERT—cervical cancer	0.000282	0.00182	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—NOTCH2—cervical cancer	0.000275	0.00178	CbGpPWpGaD
Halothane—KCNMA1—Circadian rythm related genes—TP53—cervical cancer	0.000274	0.00177	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—AKAP13—cervical cancer	0.000266	0.00171	CbGpPWpGaD
Halothane—GABRB3—BDNF signaling pathway—CASP3—cervical cancer	0.00026	0.00168	CbGpPWpGaD
Halothane—RHO—Disease—FGFR3—cervical cancer	0.000259	0.00167	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—TERT—cervical cancer	0.000255	0.00165	CbGpPWpGaD
Halothane—GABRB3—BDNF signaling pathway—CTNNB1—cervical cancer	0.000251	0.00162	CbGpPWpGaD
Halothane—RHO—Disease—NOTCH1—cervical cancer	0.000243	0.00157	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—FGFR3—cervical cancer	0.000234	0.00151	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—WNT5A—cervical cancer	0.000229	0.00148	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—HES1—cervical cancer	0.000226	0.00146	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—NOTCH1—cervical cancer	0.00022	0.00142	CbGpPWpGaD
Halothane—GABRB3—BDNF signaling pathway—STAT3—cervical cancer	0.000219	0.00141	CbGpPWpGaD
Halothane—GABRA1—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.000209	0.00135	CbGpPWpGaD
Halothane—GABRA1—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.000202	0.0013	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—TERT—cervical cancer	0.000198	0.00128	CbGpPWpGaD
Halothane—NPSR1—Signaling by GPCR—EGFR—cervical cancer	0.000196	0.00126	CbGpPWpGaD
Halothane—RHO—Disease—MTOR—cervical cancer	0.000182	0.00118	CbGpPWpGaD
Halothane—RHO—Disease—CD4—cervical cancer	0.000182	0.00117	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—FGFR3—cervical cancer	0.000182	0.00117	CbGpPWpGaD
Halothane—ATP5D—Metabolism—MTHFR—cervical cancer	0.000176	0.00113	CbGpPWpGaD
Halothane—ND1—Metabolism—MTHFR—cervical cancer	0.000176	0.00113	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—NOTCH1—cervical cancer	0.00017	0.0011	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—MTOR—cervical cancer	0.000165	0.00106	CbGpPWpGaD
Halothane—RHO—Disease—CTNNB1—cervical cancer	0.000162	0.00104	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—NOTCH2—cervical cancer	0.000161	0.00104	CbGpPWpGaD
Halothane—ALB—Folate Metabolism—TP53—cervical cancer	0.000153	0.000987	CbGpPWpGaD
Halothane—RHO—Signaling by GPCR—EGFR—cervical cancer	0.000152	0.00098	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—CASP3—cervical cancer	0.000151	0.000977	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—CTNNB1—cervical cancer	0.000146	0.000942	CbGpPWpGaD
Halothane—RHO—Disease—STAT3—cervical cancer	0.000141	0.000909	CbGpPWpGaD
Halothane—GNG2—Metabolism—MTHFR—cervical cancer	0.000139	0.000895	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—HES1—cervical cancer	0.000132	0.000852	CbGpPWpGaD
Halothane—KCNMA1—Hemostasis—TP53—cervical cancer	0.000131	0.000843	CbGpPWpGaD
Halothane—GNG2—Hemostasis—TP53—cervical cancer	0.00013	0.000838	CbGpPWpGaD
Halothane—RHO—Disease—EGFR—cervical cancer	0.000128	0.000827	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—MTOR—cervical cancer	0.000128	0.000824	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—STAT3—cervical cancer	0.000127	0.000821	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—CASP3—cervical cancer	0.000117	0.000758	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—CA9—cervical cancer	0.000116	0.00075	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—EGFR—cervical cancer	0.000116	0.000746	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—TERT—cervical cancer	0.000116	0.000746	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—CTNNB1—cervical cancer	0.000113	0.000731	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—FGFR3—cervical cancer	0.000106	0.000685	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—NOTCH1—cervical cancer	9.97e-05	0.000643	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—STAT3—cervical cancer	9.87e-05	0.000637	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—TP53—cervical cancer	9.71e-05	0.000627	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—CA9—cervical cancer	9.37e-05	0.000605	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—CA9—cervical cancer	9.18e-05	0.000592	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—EGFR—cervical cancer	8.97e-05	0.000579	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—EGFR—cervical cancer	8.88e-05	0.000573	CbGpPWpGaD
Halothane—ALB—Metabolism—CA9—cervical cancer	7.89e-05	0.000509	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—TP53—cervical cancer	7.53e-05	0.000486	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—MTOR—cervical cancer	7.47e-05	0.000482	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—CASP3—cervical cancer	6.87e-05	0.000443	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—CTNNB1—cervical cancer	6.62e-05	0.000427	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—CA9—cervical cancer	6.51e-05	0.00042	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—CA9—cervical cancer	6.46e-05	0.000417	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—STAT3—cervical cancer	5.77e-05	0.000372	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—EGFR—cervical cancer	5.25e-05	0.000338	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—MTHFR—cervical cancer	4.71e-05	0.000304	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—TP53—cervical cancer	4.4e-05	0.000284	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—CA9—cervical cancer	4.26e-05	0.000275	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—MTHFR—cervical cancer	3.8e-05	0.000245	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—MTHFR—cervical cancer	3.73e-05	0.00024	CbGpPWpGaD
Halothane—ALB—Metabolism—MTHFR—cervical cancer	3.2e-05	0.000207	CbGpPWpGaD
Halothane—ALB—Hemostasis—TP53—cervical cancer	3e-05	0.000193	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—MTHFR—cervical cancer	2.64e-05	0.000171	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—MTHFR—cervical cancer	2.62e-05	0.000169	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—MTHFR—cervical cancer	1.73e-05	0.000112	CbGpPWpGaD
